Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1984 May;9(5):595-606.
doi: 10.1007/BF00964506.

Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase

Developmental changes in the activity and substrate specificities of mouse brain monoamine oxidase

Y Koide et al. Neurochem Res. 1984 May.

Abstract

Developmental changes in monoamine oxidase (MAO) activity in the mouse brain were investigated with the substrates beta-phenylethylamine (PEA), tryptamine, and 5-hydroxytryptamine (5-HT). In the newborn brain, MAO activity towards PEA was found to be much lower than the adult and to be inhibited by clorgyline in a double-sigmoidal fashion. The inhibition curve shifted to a single-sigmoidal pattern with age. MAO activity towards 5-HT as substrate was inhibited by 90% and in a single-sigmoidal manner by clorgyline throughout the postnatal life. Lineweaver-Burk plots with PEA as substrate presented two linear lines (apparent Km: 28.6 and 4.1 microM) for the newborn and one line (apparent Km: 11.4 microM) for the adult, respectively. The plot with high Km value for the newborn brain disappeared in a clorgyline-treated preparation. These findings suggest that age-dependent alterations in the ratio of MAO-A/MAO-B activity affect the substrate specificity of the enzyme.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Brain Res. 1975 Aug 8;93(2):301-8 - PubMed
    1. Biochem Pharmacol. 1977 Dec 1;26(23):2269-74 - PubMed
    1. Neurochem Res. 1979 Feb;4(1):53-62 - PubMed
    1. FEBS Lett. 1976 Apr 15;64(1):227-30 - PubMed
    1. J Pharm Pharmacol. 1976 Sep;28(9):667-71 - PubMed